DR. MATTHEW COOPER

MDReal-Time Hydrated
Specialty: Otolaryngology
Practice Location: MANDEVILLE, LA 70471
NPI Number: 1851787444
LIFETIME INDUSTRY VALUE
$917
2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. COOPER is a verified Otolaryngology practitioner based in MANDEVILLE, LA.

Between 2021 and 2025, Dr. COOPER had an overall industry promotional and research financial footprint of $917 as recorded in the federal CMS Open Payments database.

  • $917 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
  • $0 was allocated to sponsored clinical trials and medical research activities.

Dr. COOPER's primary funding source is OPTINOSE US, which accounts for $242 (representing 26.4% of overall industry footprint).

Data coverage: 2021 – 2025  ·  Source: CMS Open Payments  ·  CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments
Research Funding
$400$200$0$712021$4002022$2432023$1042024$1002025

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

OPTINOSE US
Rank 1
$242
26.4%
MEDTRONIC
Rank 2
$166
18.1%
REGENERON HEALTHCARE SOLUTIONS
Rank 3
$155
16.9%

General payments include consulting honoraria, promotional speaking fees, meals, travel, educational materials, and entertainment offsets.

PROMOTIONAL COUNT
Active
ESTIMATED COMPLIANCE RISK
Standard

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:
2025
2025
2024
2023
2022
2021
Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.